Abstract 1383: The effect of a novel angiogenesis inhibitor (TM) on the efficacy of HSV-1 oncolytic virus
Azeem Kaka(Emory University), Balveen Kaur(Augusta University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Quintin Pan(Ohio University), E. Antonio Chiocca(Center for Cancer Research), Matthew Old, Jason Pradarelli(Northwestern University), Ted Teknos, Christopher Alvarez‐Breckenridge(Harvard University)
Cited by 0
Related Papers
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614
Multiplexed Profiling of Single Extracellular Vesicles
|ACS Nano|2017|372
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360